Resources Contact Us Home
Mechanically enhanced self-donning gown

Image Number 6 for United States Patent #7546643.

The present invention relates to mechanical self-donning gowns that permit the wearer to don the gown without the assistance of another person while ensuring that the sterility of the gown and the hands of the wearer of the gown are not compromised during the donning process. The present invention comprises essentially of a gown body, a closure element attached to the gown body, and a mechanical self-donning mechanism also attached to the gown body. The wearer dons the gown by placing one arm in each sleeve and moving the sleeves so that the mechanical donning mechanisms are moved from the initial closed configurations to a subsequent open configurations thereby engaging the gown closure element and forming the closable back portion of the gown body thereby permitting the wearer to don the gown without the assistance of another person while maintaining a sterile environment.

  Recently Added Patents
Printing apparatus and method of operation of a printing apparatus
Egg separator
Method and system for prioritizing points of interest for display in a map using category score
Storage basket with lid
Documentation roadmaps and community networking for developers on large projects
Stabilised prostaglandin composition
Network traffic demotion
  Randomly Featured Patents
Methods, functional data, and systems for image feature translation
Oxide containing MCrAlY-type overlay coatings
Thermal inkjet print head with solvent resistance
Image forming apparatus having interlocking mechanism configured to interlock developing-section displacement mechanism and photosensitive-member displacement mechanism with cover
3'-deamino-3'-hydroxy-4'-deoxy-4'-amino doxorubicin and related daunorubicin
Storage bumper
Pressure relief valve with direct hydraulic damping
Concentrated thermal radiation transfer system from electrically produced source
Suspending agent for the suspension polymerization of water-soluble monomers
Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, asparate 101 or leucine 137